Citius Oncology Inc (NASDAQ:CTOR) traded at $2.5 at close of the session on Monday, June 23 and made a downward move of -4.94%% on its previous day’s price.
Looking at the stock we see that its previous close was $2.63 and the beta (5Y monthly) reads -0.063 with the day’s price range being $2.37 – $3.07. In terms of its 52-week price range, CTOR has a high of $49.00 and a low of $0.55. The company’s stock has gained about 185.55% over that past 30 days.
Citius Oncology Inc has a market cap of $178.88 million and is expected to release its quarterly earnings report on 2025-May-14.
On the other hand, looking at the outlook for the CTOR stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of Hold.
Looking further, we note the current price level is 95.02% off its SMA20 and 152.23% from its 50-day simple moving average. The RSI (14) is pointing at 86.25 while the volatility over the past week is 25.96% and jumps to 12.32% over the past one month.
Coming back to Citius Oncology Inc (NASDAQ:CTOR), we note that the average 3-month trading volume was 1.84 million, while that of the preceding 10-day period stands at 3.86 million. Current shares outstanding are 71.55 million.
The insiders hold 95.08% of the company’s shares while institutions hold 0.15%. The data shows that short shares as of 2025-05-30, stood at 25500.0 at a short ratio of 0.52. This represents a 46.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 71001.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -77.68% down in year-to-date price movement.
